The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | BBG01JLQNZ67 | 27,098,543 | 1,895,003 | SH | SOLE | 1,895,003 | 0 | 0 | ||
| ADICET BIO INC | COM | 007002108 | BBG00JRNTRX1 | 3,229,652 | 1,374,320 | SH | SOLE | 1,374,320 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | COM NEW | 00773U207 | BBG006R62FS7 | 9,294,689 | 657,333 | SH | SOLE | 657,333 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | BBG008P2ZHB2 | 54,505,000 | 1,375,000 | SH | SOLE | 1,375,000 | 0 | 0 | ||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | BBG01H51WZ19 | 19,270,500 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | BBG00LW7YKL7 | 52,632,000 | 1,275,000 | SH | SOLE | 1,275,000 | 0 | 0 | ||
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | BBG00KVT0612 | 14,674,000 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | BBG00X93QPW2 | 27,862,837 | 3,410,384 | SH | SOLE | 3,410,384 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | BBG00QG3ZJZ0 | 18,766,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | BBG00HKBW0P2 | 33,608,606 | 1,555,954 | SH | SOLE | 1,555,954 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | BBG000FW8RX8 | 36,365,662 | 866,468 | SH | SOLE | 866,468 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG00K7T3BB4 | 43,176,000 | 6,425,000 | SH | SOLE | 6,425,000 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | BBG0076D3TF6 | 69,432 | 92,687 | SH | SOLE | 92,687 | 0 | 0 | ||
| ENGENE HOLDINGS INC | COM | 29286M105 | BBG01J3G80L6 | 21,187,500 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | BBG00RRGW9T9 | 69,889,380 | 3,973,245 | SH | SOLE | 3,973,245 | 0 | 0 | ||
| HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | BBG01L3GYVB5 | 5,200,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| IMMUNOVANT INC | COM | 45258J102 | BBG00PGVV879 | 24,264,487 | 750,990 | SH | SOLE | 750,990 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | BBG009W9FYM0 | 32,528,250 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
| KYVERNA THERAPEUTICS INC | COM | 501976104 | BBG01L9YJ1T4 | 22,658,775 | 912,189 | SH | SOLE | 912,189 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | BBG0057K7ZN6 | 4,342,694 | 295,020 | SH | SOLE | 295,020 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | BBG00B8LXN67 | 196,330,800 | 4,360,000 | SH | SOLE | 4,360,000 | 0 | 0 | ||
| MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | BBG00F13HZ84 | 54,833,330 | 5,833,333 | SH | SOLE | 5,833,333 | 0 | 0 | ||
| NEUROGENE INC | COM | 64135M105 | BBG005Y0QDR4 | 10,180,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| NKARTA INC | COM | 65487U108 | BBG00VM46C05 | 34,213,650 | 3,165,000 | SH | SOLE | 3,165,000 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | BBG011Y7F998 | 111,715,598 | 1,487,756 | SH | SOLE | 1,487,756 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | BBG00S2L1TQ6 | 27,500,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| PERSPECTIVE THERAPEUTICS INC | COM | 46489V104 | BBG000BG5J68 | 25,052,631 | 21,052,631 | SH | SOLE | 21,052,631 | 0 | 0 | ||
| PHARVARIS N V | COM | N69605108 | BBG00YYCW1Z5 | 39,864,750 | 1,725,000 | SH | SOLE | 1,725,000 | 0 | 0 | ||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG00HMVG5Q2 | 45,496,500 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
| SAB BIOTHERAPEUTICS INC | COM NEW | 78397T202 | BBG00YHY0GD2 | 831,610 | 183,174 | SH | SOLE | 183,174 | 0 | 0 | ||
| SOLENO THERAPEUTICS INC | COM | 834203309 | BBG006MJGV22 | 7,256,012 | 169,533 | SH | SOLE | 169,533 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | BBG009DXJ5Q3 | 71,463,306 | 1,884,084 | SH | SOLE | 1,884,084 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG0068BPVG0 | 7,588,654 | 318,851 | SH | SOLE | 318,851 | 0 | 0 | ||
| THIRD HARMONIC BIO INC | COM | 88427A107 | BBG019K3NPT8 | 11,800,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | BBG00V1L5Y21 | 58,746,600 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
| VERA THERAPEUTICS INC | CL A | 92337R101 | BBG010CJ1DD9 | 136,474,800 | 3,165,000 | SH | SOLE | 3,165,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG00666F7Z6 | 33,875,774 | 1,934,653 | SH | SOLE | 1,934,653 | 0 | 0 | ||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB3927 | 8,316,000 | 1,575,000 | SH | SOLE | 1,575,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | BBG0073DM7J2 | 93,323,489 | 2,167,793 | SH | SOLE | 2,167,793 | 0 | 0 | ||